文献速递神经肿瘤

MiR-181b通过靶向表皮生长因子受体调节多形性胶质母细胞瘤细胞对替莫唑胺的化疗敏感性

MiR-181b modulates chemosensitivity of glioblastoma multiforme cells to temozolomide by targeting the epidermal growth factor receptor.
PubMed 文献 · J Neurooncol · 2017-05-13

该研究探讨miR-181b调控多形性胶质母细胞瘤(GBM)细胞对替莫唑胺(TMZ)敏感性的功能与机制。qRT-PCR显示复发GBM组织中miR-181b较初发GBM组织显著下调;miR-181b过表达在体外和体内增加GBM细胞对TMZ的化疗敏感性并增强TMZ诱导的凋亡;表皮生长因子受体(EGFR)是miR-181b的直接靶点,恢复EGFR可挽救miR-181b与TMZ治疗的抑制作用。

要点

  • 复发GBM组织中miR-181b表达较初发GBM组织显著下调。
  • miR-181b过表达在体外和体内增加GBM细胞对TMZ的化疗敏感性并增强TMZ诱导的凋亡。
  • EGFR是miR-181b的直接靶点,恢复EGFR可挽救miR-181b与TMZ治疗的抑制作用。

核心结论

  • 数据强烈支持miR-181b通过靶向EGFR表达在赋予TMZ耐药中起重要作用。

研究设计与样本

  • 研究采用定量实时逆转录PCR(qRT-PCR)检测复发与初发GBM组织中miR-181b表达,并在体外和体内进行miR-181b过表达及EGFR恢复实验。

主要发现

  • qRT-PCR数据显示复发GBM组织中miR-181b较初发GBM组织显著下调。
  • miR-181b过表达增加GBM细胞对TMZ的化疗敏感性并增强TMZ诱导的凋亡,体外和体内均如此。
  • EGFR是miR-181b的直接靶点,恢复EGFR可挽救miR-181b与TMZ治疗的抑制作用。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Temozolomide (TMZ) is a promising chemotherapeutic agent to treat Glioblastoma multiforme (GBM). However, resistance to TMZ develops quickly with a high frequency. The mechanisms underlying GBM cells' resistance to TMZ are not fully understood. MicroRNAs (miRNAs) are small, non-coding RNA molecules that regulate protein expression by cleaving or repressing the translation of target mRNAs. Recently, miRNAs have been discovered to play important roles in drug resistance. A previous study showed that miR-181b in involved in glioma tumorigenesis. Thus, it would be valuable to explore the functions and mechanisms of miR-181b in regulating GMB cells' sensitivity to TMZ. In this study, quantitative real-time reverse transcription PCR (qRT-PCR) data indicated that miR-181b was significantly downregulated in recurrent GBM tissues compared with initial GBM tissues. We also found that miR-181b overexpression increased the chemo-sensitivity of GBM cells to TMZ and potentiated TMZ-induced apoptosis in vitro and in vivo. Moreover, we demonstrated that the epidermal growth factor receptor (EGFR) was a direct target of miR-181b: restoration of EGFR rescued the inhibitory effects of miR-181b and TMZ treatment. Taken together, our data support strongly an important role for miR-181b in conferring TMZ resistance by targeting EGFR expression.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Chen Y, Li R, Pan M, et al. MiR-181b modulates chemosensitivity of glioblastoma multiforme cells to temozolomide by targeting the epidermal growth factor receptor. J Neurooncol. 2017. PMID: 28501897. doi:10.1007/s11060-017-2463-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。